Silence Therapeutics
Price & Volume
Stats
See more52W Range | $5.81-$27.72 |
Market Cap | $317.2M |
Shares Short | 932,805 |
Financials
See moreRevenue (12 Mos) | $17.9M |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | $6.6M |
Diluted EPS | -$1.68 |
News
See moreYahoo Finance • last year
Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues
Yahoo Finance • last year
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
Yahoo Finance • 2 years ago
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Investor Conference
Yahoo Finance • 2 years ago
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
About
CEO | Mr. Craig A. Tooman M.B.A. |
CFO | Ms. Rhonda L. Hellums |
Address | 72 Hammersmith Road, London, United Kingdom, W14 8TH |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
